Patients taking metformin for Type 2 diabetes had a lower risk of developing osteoarthritis than did patients taking a sulfonylurea, according to a study published
The European Commission (EC) has given authorization for ruxolitinib (Opzelura) cream 15 mg/g to be marketed for treating nonsegmental vitiligo, a chronic autoimmune disease characterized by
The FDA has cleared the Beta Bionics iLet ACE Pump and the iLet Dosing Decision Software for individuals 6 years of age and older with
Researchers say about 1 in 10 individuals are now affected by autoimmune disorders and have revealed new clues on possible causes. There are more than
